{
  "cik": 2019410,
  "cik_padded": "0002019410",
  "entityName": "Caris Life Sciences, Inc.",
  "fiscal_years": [
    {
      "accn": "0002019410-26-000016",
      "filed": "2026-03-03",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 113000.0,
        "capex": 16260000.0,
        "cash": 796274000.0,
        "eps_diluted": -3.22,
        "free_cash_flow": 66895000.0,
        "net_income": -68088000.0,
        "operating_cash_flow": 83155000.0,
        "operating_income": 45113000.0,
        "revenue": 812033000.0,
        "stockholders_equity": 577307000.0,
        "total_assets": 1125663000.0,
        "total_liabilities": 548356000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.9498516387294802,
        "net_margin": -0.08384880910012278,
        "operating_margin": 0.055555623970946995,
        "revenue_growth_yoy": 0.9697108620773298,
        "roa_avg2y": -0.09267475025469632,
        "roa_period_end": -0.06048701964975308,
        "roe_avg2y": 0.07086848976154951,
        "roe_period_end": -0.11794071438593329
      }
    },
    {
      "accn": "0002019410-26-000016",
      "filed": "2026-03-03",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 8444000.0,
        "cash": 63950000.0,
        "eps_diluted": -10.66,
        "free_cash_flow": -253643000.0,
        "net_income": -281890000.0,
        "operating_cash_flow": -245199000.0,
        "operating_income": -257122000.0,
        "revenue": 412260000.0,
        "stockholders_equity": -2498838000.0,
        "total_assets": 343734000.0,
        "total_liabilities": 620921000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "net_margin": -0.6837675253480814,
        "operating_margin": -0.6236889341677582,
        "revenue_growth_yoy": 0.3466915799926828,
        "roa_period_end": -0.8200818074441283,
        "roe_avg2y": 0.1214051976532951
      }
    },
    {
      "accn": "0002019410-26-000016",
      "filed": "2026-03-03",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 22319000.0,
        "eps_diluted": -13.24,
        "free_cash_flow": -298419000.0,
        "net_income": -341415000.0,
        "operating_cash_flow": -276100000.0,
        "operating_income": -319551000.0,
        "revenue": 306128000.0,
        "stockholders_equity": -2144950000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "net_margin": -1.1152687764595202,
        "operating_margin": -1.0438476715622222,
        "roe_avg2y": 0.17749384400515406
      }
    },
    {
      "accn": "0002019410-26-000016",
      "filed": "2026-03-03",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -1702113000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0002019410-26-000016",
    "filed": "2026-03-03",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "8071",
  "sic_description": "Services-Medical Laboratories",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002019410.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0002019410.json"
  },
  "ticker": "CAI"
}